Ranbaxy Laboratories (Ranbaxy) has launched the generic versions of Atorvastatin tablets, 10mg, 20mg, 40mg and 80mg in Italy and Sweden and 10mg, 20mg and 40mg in the Netherlands, after receiving approval from the respective local regulatory authorities. In accordance with Ranbaxy’s settlement agreement with Pfizer, it has introduced the product ahead of the applicable patent expiries. Pfizer's patent expires in Italy on May 08, 2012 and in the Netherlands and Sweden on May 06, 2012.
Atorvastatin, a cholesterol reducing drug, is the largest selling pharmaceutical product in Italy with sales of $377 million, as per IMS MAT December, 2011. The market size for Atorvastatin in the Netherlands is $164.4 million, as per IMS MAT December, 2011 and in Sweden it is $55 million, as per IMS MAT December 2011 and is the largest selling Statin product in these two markets.
Ranbaxy will be promoting the drug directly to all channel partners including retail pharmacies and wholesalers in Italy and the Netherlands. In Sweden the company will be offering its drug through the official pricing and reimbursement scheme covering generic medicines, to all retail pharmacies.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1654.70 |
| Dr. Reddys Lab | 1232.00 |
| Cipla | 1229.60 |
| Zydus Lifesciences | 915.45 |
| Lupin | 2332.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: